2-Mercaptoethanol → HCID 178485283, 화합물

HRID 1816826

반응식

HRID 1816826 반응식
N[C:2]1[C:3]([N+:12]([O-])=O)=[C:4](SCCO)[CH:5]=[CH:6][CH:7]=1.Cl[C:16]1[C:17]([N+]([O-])=O)=[C:18]([CH:20]=[CH:21][CH:22]=1)N.SCC[OH:29].[C:30](=[O:33])([O-])[O-].[K+].[K+].[NH2:36][C:37]1C(N)=CC=C[C:38]=1SCCO.[NH2:48][C:49]1[CH:50]=[C:51]([CH:56]=[CH:57][C:58]=1[NH2:59])[C:52]([NH:54][CH3:55])=[O:53]>CN(C=O)C.CCOC(C)=O.[Pd]>[CH3:55][NH:54][C:52]([C:51]1[CH:56]=[CH:57][C:58]2[NH:59][C:38]([C:37]3[C:2]4[C:3](=[CH:4][C:5]([C:22]5[CH:21]=[CH:20][C:18]([OH:29])=[CH:17][C:16]=5[O:33][CH3:30])=[CH:6][CH:7]=4)[NH:12][N:36]=3)=[N:48][C:49]=2[CH:50]=1)=[O:53]

참가 물질

10

반응 조건

온도
130 °C

실험 절차

The starting material was prepared as follows: 2-(3-Amino-2-nitro-phenylsulfanyl)ethanol. 3-Chloro-2-nitro-aniline (1.12 g, 6.5 mmol), 2-mercaptoethanol (0.60 ml, 8.6 mmol), and potassium carbonate (0.99 g, 7.1 mmol) were combined in dry DMF (15 ml) and stirred at 130° C. for 4 h. The solution was allowed to cool and was concentrated in vacuo. Purification by silica gel chromatography (70% EtOAc/hexanes) gave 1.29 g (93%) of 23-amino-2-nitro phenylsulfanyl)-ethanol as a bright red solid. 1H NMR (300 MHz, DMSO-d6) δ 7.20 (t, 1H, J=8.1 Hz), 6.80 (s, 2H), 6.73 (dd, 1H, J=8.4, 0.9 Hz), 6.63 (dd, 1H, J=7.8, 1.2 Hz), 4.92 (t, 1H, J=6.0 Hz), 3.58 (q, 2H, J=6.0 Hz), 2.98 (t, 2H, J=6.0 Hz). 2-(2,3-Diamino-phenysulfanyl)-ethanol. 2-(3-Amino-2-nitrophenylsulfanyl) ethanol (1.02 g, 4.8 mmol) was reduced by hydrogenation using 45 psi of H2 with 10% Pd-C (180 mg) in EtOAc (25 mL) for 6 h. After filtering through Celite, solvent was removed in vacuo. Purification by silica gel chromatography (EtOAc) gave 762 mg (87%) of 22,3-diamino-phenylsulfanyl)ethanol as a faintly yellow solid. 1H NMR (300 MHz, CDCl3) δ 6.98 (dd, 1H, J=7.5, 1.5 Hz), 6.606.72 (m, 2H), 3.65 (t, 2H, J=5.7 Hz), 355 (br s, 5H), 2.91 (t, 2H, J=5.7 Hz). Example 25(g); 3-(5-methylcarbamoyl-1H-benzoimidazol-2-yl)-6-(2-methoxy-4 hydroxyphenyl)-1H-indazole Example 25(g) was prepared in a similar manner to that described for Example 25(a), except 3,4-diamino-N-methyl-benzamide (Kumar, et. al. J. Med. Chem, 27, 1083-89 (1984)) was used instead of 3,4-diaminopyridine in step (iv). 1H NMR (300 MHz, DMSO-d6) δ 13.59 (s, 0.5H), 13.55 (s, 0.5H), 13.21 (s, 0.5H), 13.14 (s, 0.5H), 9.60 (s, 1H), 8.38-9.46 (m, 2H), 8.26 (s, 0.5H), 8.03 (s, 0.5H), 7.71-7.79 (m, 1.5H), 7.63 (s, 1H), 7.52 (d, 0.5H, J=8.4 Hz), 7.35-7.40 (m, 1H), 7.21 (d, 1H, J=2.1 Hz), 6.55 (d, 1H, J=2.4 Hz), 6.49 (dd, 1H, J=8.4, 2.4 Hz), 3.75 (s, 3H), 2.82 (d, 1.5H, J=1.5 Hz). 2.81 (d, 1.5H, J=1.5 Hz). MS (ES) [m+H]/z calc'd 414, found 414, [m−H]/z calc'd 412, found 412.

후처리

  1. customThe starting material was prepared
  2. temperatureto cool
  3. concentrationwas concentrated in vacuo
  4. customPurification by silica gel chromatography (70% EtOAc/hexanes)
  5. customgave 1.29 g (93%) of 23-amino-2-nitro phenylsulfanyl)-ethanol as a bright red solid
  6. customfor 6 h
  7. filtrationAfter filtering through Celite, solvent
  8. customwas removed in vacuo
  9. customPurification by silica gel chromatography (EtOAc)
  10. customgave 762 mg (87%) of 22,3-diamino-phenylsulfanyl)ethanol as a faintly yellow solid

출처 및 근거

ORD 기록
ord-382a6fad4d0e495f841289f836e64fca
출처 데이터셋
uspto-grants-2005_04
특허 번호
US06884890B2

연결된 노트

불러오는 중…